Top

Published in:

01-06-2022 | Geriatric Oncology | Clinical study

Immune-related AEs due to ICIs more likely in older patients

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Immune-related adverse events (irAEs) due to immune checkpoint inhibitor (ICI) therapy are reported more frequently in older patients than in younger adults, according to findings of a study published in the Journal of Geriatric Oncology. …

Chen C, et al. Immune-related adverse events in older adults: Data mining of the FDA Adverse Event Reporting System Journal of Geriatric Oncology : 20 Jun 2022. Available from: URL: https://doi.org/10.1016/j.jgo.2022.05.009

Title: Immune-related AEs due to ICIs more likely in older patients
Publication date: 01-06-2022
Publisher: Springer International Publishing
Keywords: Geriatric Oncology
Geriatric Oncology
Checkpoint Inhibitors
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-17714-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Immune-related AEs due to ICIs more likely in older patients

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Multiple drugs

Multiple drugs

Antidepressants/anxiolytics/salmeterol

Diazoxide/glucose

Tozinameran

Entecavir/methylprednisolone/mycophenolate-sodium